类风湿关节炎诊断时的合并症:一项基于人群的病例对照研究
结果显示RA患者呼吸系统、内分泌及某些神经系统疾病更常见,而精神疾病和恶性肿瘤诊断更少,总体合并症负担略高。
要点
- 新发RA诊断时呼吸、内分泌及某些神经系统疾病较普通人群更常见。
- 精神疾病与恶性肿瘤在新发RA中诊断比例低于对照人群。
- 血清阳性和血清阴性RA的合并症模式相似,总体合并症负担略高。
核心结论
- 新发RA患者在诊断时已存在与普通人群不同的合并症谱,总体合并症负担略高于对照。
主要发现
- RA诊断时呼吸系统疾病OR=1.58(95%CI:1.44,1.74),内分泌疾病OR=1.39(95%CI:1.31,1.47),某些神经系统疾病OR=1.73(95%CI:1.59,1.89),均较对照更常见。
- 精神疾病OR=0.87(95%CI:0.82,0.92)和恶性肿瘤OR=0.88(95%CI:0.79,0.97)在RA中诊断比例低于对照。
- 血清阳性和血清阴性RA的合并症模式相似,RA总体合并症负担略高于对照(P<0.0001)。
关键数值与推荐
- 呼吸系统疾病OR=1.58(95%CI:1.44,1.74)。
- 内分泌疾病OR=1.39(95%CI:1.31,1.47)。
- 某些神经系统疾病OR=1.73(95%CI:1.59,1.89)。
- 精神疾病OR=0.87(95%CI:0.82,0.92)。
- 恶性肿瘤OR=0.88(95%CI:0.79,0.97)。
临床怎么用
- 在RA诊断初期即应关注呼吸系统、内分泌及神经系统合并症,并纳入早期评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Comorbidities contribute to the morbidity and mortality in RA, and are thus important to capture and treat early. In contrast to the well-studied comorbidity risks in established RA, less is known about the comorbidity pattern up until diagnosis of RA. We therefore compared whether the occurrence of defined conditions, and the overall comorbidity burden at RA diagnosis, is different from that in the general population, and if it differs between seropositive and seronegative RA. METHODS: Using Swedish national clinical and demographic registers, we identified new-onset RA patients (n = 11 086), and matched (1:5) to general population controls (n = 54 813). Comorbidities prior to RA diagnosis were identified in the Patient and Prescribed Drug Registers, and compared using logistic regression. RESULTS: At diagnosis of RA, respiratory (odds ratio (OR) = 1.58, 95% CI: 1.44, 1.74), endocrine (OR = 1.39, 95% CI: 1.31, 1.47) and certain neurological diseases (OR = 1.73, 95% CI: 1.59, 1.89) were more common in RA vs controls, with a similar pattern in seropositive and seronegative RA. In contrast, psychiatric disorders (OR = 0.87, 95% CI: 0.82, 0.92) and malignancies (OR = 0.88, 95% CI: 0.79, 0.97) were less commonly diagnosed in RA vs controls. The comorbidity burden was slightly higher in RA patients compared with controls (P <0.0001). CONCLUSION: We found several differences in comorbidity prevalence between patients with new-onset seropositive and seronegative RA compared with matched controls from the general population. These findings are important both for our understanding of the evolvement of comorbidities in established RA and for early detection of these conditions.
引用
- Tidblad L, Westerlind H, Delcoigne B, et al. Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study. Rheumatology (Oxford). 2021. PMID: 33331937. doi:10.1093/rheumatology/keaa856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。